AtriCure Dividend

Dividend criteria checks 0/6

AtriCure does not have a record of paying a dividend.

Key information

n/a

Dividend yield

n/a

Payout ratio

Industry average yield1.8%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share-US$0.52
Dividend yield forecast in 3Y0%

Recent dividend updates

No updates

Recent updates

Is AtriCure (NASDAQ:ATRC) Using Debt In A Risky Way?

Nov 29
Is AtriCure (NASDAQ:ATRC) Using Debt In A Risky Way?

AtriCure, Inc.'s (NASDAQ:ATRC) Intrinsic Value Is Potentially 99% Above Its Share Price

Sep 27
AtriCure, Inc.'s (NASDAQ:ATRC) Intrinsic Value Is Potentially 99% Above Its Share Price

Health Check: How Prudently Does AtriCure (NASDAQ:ATRC) Use Debt?

Aug 02
Health Check: How Prudently Does AtriCure (NASDAQ:ATRC) Use Debt?

AtriCure, Inc.'s (NASDAQ:ATRC) Share Price Matching Investor Opinion

Jun 15
AtriCure, Inc.'s (NASDAQ:ATRC) Share Price Matching Investor Opinion

Is AtriCure (NASDAQ:ATRC) Weighed On By Its Debt Load?

Apr 14
Is AtriCure (NASDAQ:ATRC) Weighed On By Its Debt Load?

Calculating The Intrinsic Value Of AtriCure, Inc. (NASDAQ:ATRC)

Mar 02
Calculating The Intrinsic Value Of AtriCure, Inc. (NASDAQ:ATRC)

What Does AtriCure, Inc.'s (NASDAQ:ATRC) Share Price Indicate?

Feb 09
What Does AtriCure, Inc.'s (NASDAQ:ATRC) Share Price Indicate?

Is AtriCure (NASDAQ:ATRC) Using Debt In A Risky Way?

Dec 28
Is AtriCure (NASDAQ:ATRC) Using Debt In A Risky Way?

Is Now An Opportune Moment To Examine AtriCure, Inc. (NASDAQ:ATRC)?

Sep 06
Is Now An Opportune Moment To Examine AtriCure, Inc. (NASDAQ:ATRC)?

An Intrinsic Calculation For AtriCure, Inc. (NASDAQ:ATRC) Suggests It's 29% Undervalued

Aug 02
An Intrinsic Calculation For AtriCure, Inc. (NASDAQ:ATRC) Suggests It's 29% Undervalued

AtriCure: 5x Sales For A Series Of Impeding Losses? No Thanks

Jun 13

Is AtriCure (NASDAQ:ATRC) Weighed On By Its Debt Load?

Jun 08
Is AtriCure (NASDAQ:ATRC) Weighed On By Its Debt Load?

Is It Time To Consider Buying AtriCure, Inc. (NASDAQ:ATRC)?

May 08
Is It Time To Consider Buying AtriCure, Inc. (NASDAQ:ATRC)?

Is AtriCure, Inc. (NASDAQ:ATRC) Expensive For A Reason? A Look At Its Intrinsic Value

Apr 11
Is AtriCure, Inc. (NASDAQ:ATRC) Expensive For A Reason? A Look At Its Intrinsic Value

Is AtriCure (NASDAQ:ATRC) A Risky Investment?

Feb 18
Is AtriCure (NASDAQ:ATRC) A Risky Investment?

Why AtriCure, Inc. (NASDAQ:ATRC) Could Be Worth Watching

Jan 20
Why AtriCure, Inc. (NASDAQ:ATRC) Could Be Worth Watching

Robust Earnings May Not Tell The Whole Story For AtriCure (NASDAQ:ATRC)

Nov 11
Robust Earnings May Not Tell The Whole Story For AtriCure (NASDAQ:ATRC)

Does AtriCure (NASDAQ:ATRC) Have A Healthy Balance Sheet?

Oct 21
Does AtriCure (NASDAQ:ATRC) Have A Healthy Balance Sheet?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if ATRC's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ATRC's dividend payments have been increasing.


Dividend Yield vs Market

AtriCure Dividend Yield vs Market
How does ATRC dividend yield compare to the market?
SegmentDividend Yield
Company (ATRC)n/a
Market Bottom 25% (US)1.6%
Market Top 25% (US)4.8%
Industry Average (Medical Equipment)1.8%
Analyst forecast in 3 Years (ATRC)0%

Notable Dividend: Unable to evaluate ATRC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ATRC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate ATRC's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as ATRC has not reported any payouts.


Discover strong dividend paying companies

Price7D1Y
Mkt CapP/EGrowth
Price7D1Y
Mkt CapP/EGrowth
Price7D1Y
Mkt CapP/EGrowth
Price7D1Y
Mkt CapP/EGrowth